Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng Qian

Showing results (931-940 of 942) with videos related to

Pageof 95
Sort By:
Experimental & Molecular Medicine|August 30, 2022
MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axisJunqing Gan, Shan Liu, Yu Zhang, et al.
Iscience|July 23, 2024
Humoral and cellular immune responses following Omicron BA.2.2 breakthrough infection and Omicron BA.5 reinfectionXin-Jing Zhao, Bin Ji, Chao Shang, et al.
Cancer Research|March 30, 2013
β-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinomaChuan Xu, Dan Xie, Shi-Cang Yu, et al.
British Journal of Haematology|April 12, 2018
Treatment of acute lymphoblastic leukaemia with the second generation of CD19 CAR-T containing either CD28 or 4-1BBShiqi Li, Jiasi Zhang, Meiling Wang, et al.
Nature Cancer|February 27, 2026
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trialYang Gao, Jie Li, Hangyu Zhang, et al.
Iscience|May 15, 2024
The application of large language models in medicine: A scoping reviewXiangbin Meng, Xiangyu Yan, Kuo Zhang, et al.
Cell Host & Microbe|November 26, 2025
The microbial metabolite imidazole propionate modulates hypothalamic activity and stress-induced behaviorsGulistan Agirman, Michael N B Quicho, Kaden K Connelley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2019
Sustained Therapeutic Efficacy of Humanized Anti-CD19 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Acute Lymphoblastic LeukemiaGang Heng, Jiankun Jia, Shiqi Li, et al.
Hepatology International|April 8, 2020
Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide studyZhen-Hua Chen, Xiu-Ping Zhang, Yu-Gang Lu, et al.
Nature Genetics|January 13, 2025
Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promotersNaitao Wang, Mohini R Pachai, Dan Li, et al.
Pageof 95

Showing results (931-940 of 942) with videos related to

Sort By:
Pageof 95
Experimental & Molecular Medicine|August 30, 2022
MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axisJunqing Gan, Shan Liu, Yu Zhang, et al.
Iscience|July 23, 2024
Humoral and cellular immune responses following Omicron BA.2.2 breakthrough infection and Omicron BA.5 reinfectionXin-Jing Zhao, Bin Ji, Chao Shang, et al.
Cancer Research|March 30, 2013
β-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinomaChuan Xu, Dan Xie, Shi-Cang Yu, et al.
British Journal of Haematology|April 12, 2018
Treatment of acute lymphoblastic leukaemia with the second generation of CD19 CAR-T containing either CD28 or 4-1BBShiqi Li, Jiasi Zhang, Meiling Wang, et al.
Nature Cancer|February 27, 2026
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trialYang Gao, Jie Li, Hangyu Zhang, et al.
Iscience|May 15, 2024
The application of large language models in medicine: A scoping reviewXiangbin Meng, Xiangyu Yan, Kuo Zhang, et al.
Cell Host & Microbe|November 26, 2025
The microbial metabolite imidazole propionate modulates hypothalamic activity and stress-induced behaviorsGulistan Agirman, Michael N B Quicho, Kaden K Connelley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2019
Sustained Therapeutic Efficacy of Humanized Anti-CD19 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Acute Lymphoblastic LeukemiaGang Heng, Jiankun Jia, Shiqi Li, et al.
Hepatology International|April 8, 2020
Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide studyZhen-Hua Chen, Xiu-Ping Zhang, Yu-Gang Lu, et al.
Nature Genetics|January 13, 2025
Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promotersNaitao Wang, Mohini R Pachai, Dan Li, et al.
Pageof 95